Skip to content

Psychiatric Nurse-Delivered Eye Movement Desensitization and Reprocessing (EMDR) for Adults With Post-Traumatic Stress Symptoms in Jordan

Psychiatric Nurse-Delivered Eye Movement Desensitization and Reprocessing (EMDR) for Adults With Post-Traumatic Stress Symptoms in Jordan: A Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07423832
Acronym
Experimental
Enrollment
70
Registered
2026-02-20
Start date
2023-03-15
Completion date
2024-02-14
Last updated
2026-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PTSD - Post Traumatic Stress Disorder

Keywords

PTSD, EMDR, SEVERITY OF SYMPTOMS, JORDAN

Brief summary

Here is a plain-language, registry-appropriate Brief Summary you can paste into the form. It is written for patients, families, and healthcare providers: Brief Summary This study examines whether Eye Movement Desensitization and Reprocessing (EMDR) therapy can reduce the severity of symptoms in adults experiencing post-traumatic stress disorder (PTSD) in Jordan. PTSD can develop after exposure to distressing or traumatic life events and may cause symptoms such as intrusive memories, avoidance, sleep problems, anxiety, and emotional distress. A total of 70 adult participants with moderate to severe PTSD symptoms were enrolled. Participants were assigned to one of two groups: an EMDR therapy group or a waitlist control group. Individuals in the EMDR group received structured therapy sessions delivered by a trained mental-health professional, while those in the waitlist group did not receive therapy during the study period but were offered treatment after the study ended. PTSD symptom severity was measured before treatment, immediately after the therapy sessions, and again one month later. The goal of the study was to determine whether EMDR therapy leads to meaningful and lasting reductions in PTSD symptoms compared with no immediate treatment. The findings of this research are intended to help healthcare providers and policymakers understand the value of EMDR as a non-pharmacological, evidence-based treatment option for individuals experiencing trauma-related distress, and to support improvements in mental-health services and trauma-informed care in Jordan.

Detailed description

Post-traumatic stress disorder (PTSD) is a mental-health condition that may develop after exposure to traumatic or highly distressing events and is associated with significant functional, emotional, and physical consequences. Evidence-based psychological therapies are essential to reduce symptom burden and improve quality of life, particularly in settings where access to specialized trauma services may be limited. This study evaluates the effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) therapy, a structured, trauma-focused psychotherapeutic approach, in reducing the severity of PTSD symptoms among adults in Jordan. The investigation uses a quasi-experimental design with an intervention group receiving EMDR sessions and a waitlist control group receiving no immediate therapeutic intervention during the study period. Symptom severity is assessed at baseline, immediately after completion of the intervention, and at a one-month follow-up to examine both immediate and short-term outcomes. EMDR therapy is delivered by a licensed mental-health professional trained in the standardized EMDR protocol. The intervention focuses on processing traumatic memories through guided recall combined with bilateral stimulation techniques (such as eye movements), with the aim of decreasing emotional distress and strengthening adaptive cognitive responses. Participants in the waitlist control group are offered the same therapeutic sessions after completion of outcome assessments to ensure equitable access to care. The study seeks to generate empirical evidence regarding the clinical utility, feasibility, and short-term sustainability of EMDR therapy in a Middle Eastern context. Findings are intended to inform mental-health practitioners, nursing professionals, and healthcare decision-makers about the potential role of EMDR as a non-pharmacological, trauma-informed treatment option for adults experiencing moderate to severe PTSD symptoms.

Interventions

BEHAVIORALEMDR

Participants received Eye Movement Desensitization and Reprocessing (EMDR) therapy, a structured trauma-focused psychotherapy delivered individually by a licensed psychiatric mental-health professional trained in the standardized EMDR protocol. Sessions lasted approximately 90 minutes and were conducted three times per week over the intervention period. The protocol followed the established EMDR phases, including history taking, preparation, identification of target memories, bilateral stimulation (e.g., guided eye movements or alternating taps), installation of adaptive cognitions, body scan, closure, and reevaluation. Outcomes were measured at baseline, immediately post-intervention, and at one-month follow-up.

Sponsors

Al-Quds University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

No masking was implemented. Participants, intervention providers, and outcome assessors were aware of group allocation throughout the study.

Intervention model description

This study used a two-arm parallel assignment design in which eligible participants were allocated to either an EMDR intervention group or a waitlist control group. Outcomes were assessed at baseline, immediately post-intervention, and at one-month follow-up. Participants in the control arm did not receive active treatment during the study period but were offered EMDR therapy after completion of outcome assessments. No crossover between groups occurred during the trial.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adults aged 18 years or older Probable PTSD or moderate-to-severe post-traumatic stress symptoms based on the screening instrument used in the study Exposure to at least one traumatic or highly stressful life event within the previous six months No prior receipt of EMDR therapy Willingness and ability to provide informed consent and participate in therapy sessions and assessments

Exclusion criteria

Acute cognitive or intellectual disability that would interfere with comprehension of study procedures or questionnaires Significant visual impairment or visual pathology that would prevent full engagement with the visual components of EMDR therapy Inability to communicate effectively by phone for scheduled assessments Refusal or inability to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Severity of post-traumatic stress symptomsBaseline, immediately after intervention, and 1-month follow-up.Severity of post-traumatic stress symptoms measured using the Primary Care Post-Traumatic Stress Disorder Screen (PC-PTSD) questionnaire at baseline (T0), immediately post-intervention (T1), and one-month follow-up (T2).

Countries

Jordan

Contacts

STUDY_DIRECTORAyman M. Hamdan-Mansour, Professor

The University of Jordan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 19, 2026